Literature DB >> 4607883

Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and CIS-platinum (II) diaminedichloride (NSC 119875).

R A Ellerby, H L Davis, F J Ansfield, G Ramirez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4607883     DOI： 10.1002/1097-0142(197410)34:4<1005::aid-cncr2820340407>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma.

Authors:  N J Petrelli; S Madejewicz; Y Rustum; L Herrera; P J Creaven; J Plager; J Soloman; A Mittelman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects.

Authors:  C F Pollera; P Marolla; M Nardi; F Ameglio; L Cozzo; F Bevere
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

4.  Intra-hepato-arterial infusions of cis-diamminedichloroplatinum (II) and 5-fluorouracil clinically effective for malignant liver tumors.

Authors:  M Maeta; S Koga; H Yoshioka; A Murakami; T Wakatsuki
Journal:  Jpn J Surg       Date:  1985-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.